NASDAQ · Biotechnology

COGT (COGT) Stock

$42.27 -1.33% NASDAQ: COGT Healthcare

Valuation

MetricValue
Price$42.27
Market Cap$7.22B
P/E Ratio-34.70
P/B Ratio10.44
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$43.73
52-Week Low$6.92
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-85.72%
ROA-38.13%
ROCE-52.28%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.39
Current Ratio14.22

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-76.0M$-148.0M$-208.0M$-276.0M$-333.0M
Net Profit$-72.0M$-140.0M$-192.0M$-256.0M$-329.0M
EPS$-1.85$-2.26$-2.42$-2.46$-2.55
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$232.0M$301.0M$313.0M$328.0M$938.0M
Total Liabilities$18.0M$45.0M$56.0M$72.0M$301.0M
Cash$220.0M$140.0M$53.0M$98.0M$312.0M
Borrowings$3.0M$20.0M$19.0M$17.0M$253.0M

Latest News

Cogent Bioscience (COGT) Files New Drug Application For Bezuclastinib Insider Monkey · Jul 15, 2026 MEDevice Boston 2026: East Coast's Top Medical Device Conference Opens Registration for August 26-27 Event GlobeNewswire · Jul 6, 2026 Cogent Biosciences Submits US FDA New Drug Application for Potential Mast Cell Disease Treatment MT Newswires · Jun 30, 2026 Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM) GlobeNewswire · Jun 30, 2026 Is Cogent Biosciences (COGT) ’s New Cancer Drug 100 Times More Precise Than What’s Already on the Market? Insider Monkey · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-59.0M$-119.0M$-154.0M$-208.0M$-264.0M
Investing Cash Flow$-3.0M$-132.0M$-101.0M$38.0M$-401.0M
Financing Cash Flow$0$2.0M$0$1.0M$-49.0M
Net Cash Flow$-23.0M$-80.0M$-88.0M$45.0M$214.0M
Free Cash Flow$-60.0M$-126.0M$-156.0M$-208.0M$-266.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-14.17
FCF Yield-5.05%
Quick Ratio15.14
Interest Coverage-111.00
Return 1Y222.28%
Return 3Y224.65%
Return 5Y494.30%

Ownership

Insiders Held0.43%
Institutions Held112.94%
Institutions Float Held113.43%
Institutional HolderSharesReport Date
FMR, LLC23,122,7482026-03-31
Blackrock Inc.16,045,0142026-03-31
Deerfield Management Company, L.P9,043,9032026-03-31
Vanguard Portfolio Management LLC7,333,3332026-03-31
Vanguard Capital Management LLC6,894,9592026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AGIO $31.72 +0.38% -3.56 $1.89B 0.00%
DNLI $24.42 +1.03% -6.20 $3.88B 0.00%
ETNB89bio, Inc. $14.84 +0.00% -12.82 $2.20B 0.00%
GLPGGalapagos N.V. $27.98 +1.71% 3.57 $1.84B 0.00%
IBRXImmunityBio, Inc. $7.00 -1.48% -8.32 $7.33B 0.00%

About COGT

COGT is led by CEO Andrew R. Robbins, employs 258 people, headquartered in Waltham, US, publicly traded since 2018.

COGT stock trades at $42.27 with a market capitalization of $7.22B. The stock is valued at a price-to-earnings (P/E) ratio of -34.70, price-to-book of 10.44, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $6.92 and $43.73, and currently trades 3.3% below its 52-week high.

On profitability, COGT generates a return on equity (ROE) of -85.72%, return on capital employed of -52.28%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides